Statistics by Country for Androgen Insensitivity Syndrome
Prevalance of Androgen Insensitivity Syndrome:
very rare
About extrapolations of prevalence and incidence statistics for Androgen Insensitivity Syndrome:
WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries.
These statistics are calculated extrapolations of various prevalence or incidence rates
against the populations of a particular country or region.
The statistics used for prevalence/incidence of Androgen Insensitivity Syndrome are typically based on US, UK, Canadian or Australian prevalence or incidence statistics,
which are then extrapolated using only the population of the other country.
This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences
across the various countries and regions for which the extrapolated Androgen Insensitivity Syndrome statistics below refer to.
The extrapolation does not use data sources or statistics about any country other than its population.
As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication)
as to the actual prevalence or incidence of Androgen Insensitivity Syndrome in that region.
These statistics are presented only in the hope that they may be interesting to some people.
About prevalence and incidence statistics in general for Androgen Insensitivity Syndrome:
The word 'prevalence' of Androgen Insensitivity Syndrome usually means the estimated population
of people who are managing Androgen Insensitivity Syndrome at any given time (i.e. people with Androgen Insensitivity Syndrome).
The term 'incidence' of Androgen Insensitivity Syndrome means the annual diagnosis rate,
or the number of new cases of Androgen Insensitivity Syndrome diagnosed each year (i.e. getting Androgen Insensitivity Syndrome).
Hence, these two statistics types can differ:
a short disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.
New research shows some men with very late-stage prostate cancer may benefit from chemotherapy. Learn why doctors are changing their minds about the...
The most common cancer in men is also the most complicated to treat. Listen to experts describe the latest in screening, diagnosis and treatment.
The PSA test remains a controversial screening tool for prostate cancer, but there is little doubt on its value for helping with treatment decisions....
The approval of Gleevec (imatinib) in 2001 changed the future for patients with chronic myeloid leukemia (CML). CML is now one of the most treatable...
See full list of 7 related videos
» Next page: Medical News Summaries About Androgen Insensitivity Syndrome
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
